tiprankstipranks
Hepion Pharmaceuticals (HEPA)
NASDAQ:HEPA
US Market

Hepion Pharmaceuticals (HEPA) Financial Statements

Compare
761 Followers

Hepion Pharmaceuticals Financial Overview

Hepion Pharmaceuticals's market cap is currently $658.80K. The company's EPS TTM is $-219.336; its P/E ratio is ―; Hepion Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -48.45M$ -45.49M$ -30.40M$ -20.15M$ -7.77M
EBITDA$ -49.26M$ -45.00M$ -32.63M$ -20.23M$ -7.26M
Net Income$ -48.93M$ -42.20M$ -32.72M$ -20.35M$ -7.42M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 18.09M$ 60.24M$ 103.55M$ 48.65M$ 20.61M
Total Debt$ 209.02K$ 53.61K$ 316.99K$ 752.17K$ 807.45K
Net Debt$ -14.58M$ -51.14M$ -91.03M$ -39.97M$ -13.12M
Total Liabilities$ 10.81M$ 10.39M$ 10.56M$ 8.12M$ 4.99M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -40.91M$ -34.98M$ -31.35M$ -16.25M$ -7.69M
Operating Cash Flow$ -40.89M$ -34.96M$ -31.22M$ -16.17M$ -7.63M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Hepion Pharmaceuticals Debt to Assets

Hepion Pharmaceuticals Cash Flow

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis